Afila Thasnim: Blood Crossmatching Challenges and Safe Transfusion Decisions
Afila Thasnim, Former Medical Laboratory Technologist at M.K.Haji Orphanage Hospital, shared a post on LinkedIn:
“When No Compatible Unit is Available
In complex cases such as patients with warm autoantibodies, every donor unit may appear incompatible during testing.
After comprehensive antibody identification and exclusion of clinically significant alloantibodies, the transfusion service may recommend the least incompatible blood unit only when the clinical need for transfusion outweighs the potential risks.
Such decisions require close collaboration between the blood bank, transfusion medicine specialist, and treating clinician, with continuous patient monitoring throughout transfusion.
Key Takeaway
Accurate crossmatching is one of the most critical responsibilities of the blood bank laboratory. Every incompatible reaction deserves systematic investigation—not assumptions.
Selecting the most appropriate blood unit requires scientific expertise, standardized laboratory practices, and effective communication between laboratory professionals and clinicians.
Safe transfusion begins with accurate testing, evidence-based decision-making, and an unwavering commitment to patient safety.”
Stay updated with Hemostasis Today.
-
Jul 27, 2026, 17:15ISTH 2026 Congress Paris Opens with a Powerful Message: Science Beyond Border
-
Jul 27, 2026, 17:14Michael Ombrello։ Decoding How Autoantibodies Cause Disease
-
Jul 27, 2026, 16:57Thomas Dayspring։ Could PCSK9 Inhibitors Reduce the Risk of Retinal Vascular Occlusions?
-
Jul 27, 2026, 16:53Arun V. J.: How to Find a Mentor When You Know No One
-
Jul 27, 2026, 16:45Urtė Cholinaitė: A Meaningful Experience at the Lithuania Hemophilia Society Summer Camp
-
Jul 27, 2026, 16:33Martyna Lewand: Major Immunology Deal Brings FB102 to argenx
-
Jul 27, 2026, 16:30Jean Amiral: Laboratory differentiation of HIT, VITT and PF4 dependent Thrombocytopenias
-
Jul 27, 2026, 14:30William McKeown Elected Vice-President of the EHC
-
Jul 27, 2026, 13:54Nahid A. Qushmaq: Advancing Anticoagulation Through Factor XI/XIa Inhibition